 | • レポートコード：B-MOR-08294 • 出版社/出版日：Mordor Intelligence / 2018年5月18日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、体外診断の世界市場について調べ、体外診断の世界規模、市場動向、市場環境、技術別（免疫化学、POC診断、分子診断、血液学、組織診断、微生物、自己血糖モニタリング、その他）分析、製品別（器具、試薬、データ管理システム）分析、有用性別分析、用途別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・体外診断の世界市場インサイト ・体外診断の世界市場環境 ・体外診断の世界市場動向 ・体外診断の世界市場規模 ・体外診断の世界市場規模：技術別（免疫化学、POC診断、分子診断、血液学、組織診断、微生物、自己血糖モニタリング、その他） ・体外診断の世界市場規模：製品別（器具、試薬、データ管理システム） ・体外診断の世界市場規模：有用性別 ・体外診断の世界市場規模：用途別 ・体外診断の世界市場規模：エンドユーザー別 ・体外診断の世界市場：地域別市場規模・分析 ・体外診断の北米市場規模・予測 ・体外診断のアメリカ市場規模・予測 ・体外診断のヨーロッパ市場規模・予測 ・体外診断のアジア市場規模・予測 ・体外診断の日本市場規模・予測 ・体外診断の中国市場規模・予測 ・体外診断のインド市場規模・予測 ・体外診断の韓国市場規模・予測 ・関連企業情報・競争状況 |
In-vitro diagnostics (IVD) are the medical devices and consumables are utilized to perform in-vitro tests on various biological samples. In-vitro diagnostics are used for diagnosis of various medical conditions. The global in-vitro diagnostics market is expected to register a CAGR of 5.5% during the forecast period of 2018–2023.
Advanced Technologies Spurring the IVD Market
The field of in-vitro diagnostics has witnessed several changes and additions to its gamut of offerings in the recent past. There has been a paradigm shift from traditional diagnostics to a new generation diagnostics that work on gene level. This was possible due to the inclusion of advanced technology, such as genetic testing, molecular diagnostics, Polymerase Chain Reaction (PCR), and Next-Generation Sequencing (NGS). Fast turnaround, reliability, user-friendliness, and predictability of predisposed diseases are few significant qualities, which helped these technologies attain their share in major offerings of diagnosis providers around the world. Increasing demand from the educated public for more information about their predisposition for serious diseases, and how these potential illnesses can be detected at an early stage, is driving the market for in-vitro diagnostics.
High prevalence of chronic and infectious diseases, increasing use of point of care (POC) diagnostics, and surging number of private hospitals and independent testing laboratories are some of the other factors contributing to the growth of the market.
Cumbersome Reimbursement Procedure
The lack of proper reimbursement system around the globe poses to be a major restraining factor for the in-vitro diagnostics market. The process of securing reimbursement and funding for a diagnostic test on a global scale is extremely challenging. Stakeholders need to recognize what knowledge the payers/purchasers are looking for. This asks for extensive research and interpretation of a very large amount of data. Moreover, international reimbursement structures vary from country to country; hence, interested parties have to come up with new and effective strategies frequently, making it a cumbersome and tedious task hindering the market.
Additionally, stringent regulations across the globe and limited budget of hospitals and laboratories in developing economies are also restraining the in-vitro diagnostics market.
Asia-Pacific to be Lucrative
The global in-vitro diagnostics market is segmented by technique, products, usability, application, end users, and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
The reasons for Asia-Pacific being a lucrative marketplace include an increase in government healthcare expenditure and increase in per capita healthcare spending. Moreover, increase in patient awareness and demand for technological advancements in the field of in-vitro diagnostics are further driving the market growth in the region.
Key Developments in the Market
• February 2015 – Roche acquired Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer.
Key players: BIOMÉRIEUX, DANAHER CORPORATION, ROCHE DIAGNOSTICS, BECTON, DICKINSON AND COMPANY, BIO-RAD LABORATORIES, INC., ABBOTT LABORATORIES, BAYER AG, ARKRAY, INC., SYSMEX CORPORATION, JOHNSON & JOHNSON, and SIEMENS AG, among others..
Reasons to Purchase The Report
• Market analysis for the in-vitro diagnostics market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s Five Forces Analysis.
• Identify the treatment type that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 High Prevalence of Chronic and Infectious Diseases
6.1.2 Increasing Use of Point of Care (POC) Diagnostics Fueling the IVD Market
6.1.3 Advanced Technologies Spurring the IVD Market
6.1.4 Increasing Number of Private Hospitals and Independent Testing Laboratories
6.2 Restraints
6.2.1 Stringent Regulations Across the Globe
6.2.2 Cumbersome Reimbursement Procedure
6.2.3 Limited Budget of Hospitals and Laboratories in Developing Economies
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Technique
7.1.1 Immunochemistry
7.1.2 POC Diagnostics
7.1.3 Molecular Diagnostics
7.1.4 Hematology
7.1.5 Tissue Diagnostics
7.1.6 Microbiology
7.1.7 Self-Blood Glucose Monitoring
7.1.8 Others
7.2 By Products
7.2.1 Instruments
7.2.2 Reagents
7.2.3 Data Management Systems
7.3 By Usability
7.3.1 Disposable IVD Devices
7.3.2 Reusable IVD Devices
7.4 By Application
7.4.1 Infectious Diseases
7.4.2 Diabetes
7.4.3 Cancer/Oncology
7.4.4 Cardiology
7.4.5 Autoimmune Diseases
7.4.6 Nephrology
7.4.7 Drug Testing
7.4.8 HIV/AIDS
7.4.9 Others
7.5 By End Users
7.5.1 Laboratories
7.5.2 Hospitals
7.5.3 Academia
7.5.4 POC Testing
7.5.5 Others
7.6 By Geography
7.6.1 North America
7.6.1.1 United States
7.6.1.2 Canada
7.6.1.3 Mexico
7.6.1.4 Rest of North America
7.6.2 Europe
7.6.2.1 France
7.6.2.2 United Kingdom
7.6.2.3 Germany
7.6.2.4 Italy
7.6.2.5 Spain
7.6.2.6 Rest of Europe
7.6.3 Asia-Pacific
7.6.3.1 India
7.6.3.2 China
7.6.3.3 Japan
7.6.3.4 Australia
7.6.3.5 South Korea
7.6.3.6 Rest of Asia-Pacific
7.6.4 Middle East & Africa
7.6.4.1 GCC
7.6.4.2 South Africa
7.6.4.3 Rest of Middle East & Africa
7.6.5 South America
7.6.5.1 Brazil
7.6.5.2 Argentina
7.6.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Biomérieux
9.2 Danaher Corporation
9.3 Roche Diagnostics
9.4 Becton, Dickinson and Company
9.5 Bio-Rad Laboratories, Inc.
9.6 Abbott Laboratories
9.7 Bayer AG
9.8 Arkray, Inc.
9.9 Sysmex Corporation
9.10 Johnson & Johnson
9.11 Siemens AG
*List not Exhaustive
10. Future of the Market